Surveillance of patients with inflammatory bowel disease

• Published in: Baillière's best practice & research. Clinical gastroenterology Vol. 30; no. 6; pp. 949 - 958
• Main Authors: Yu, Jessica X., MD, East, James E., MD(Res), FRCP, Kaltenbach, Tonya, MD MAS
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.12.2016; Elsevier Limited
• Subjects: Biopsy; Chromoendoscopy; Colonoscopy; Colonoscopy - methods; Colorectal cancer; Colorectal Neoplasms - diagnosis; Dysplasia; Early Detection of Cancer; Endoscopy; Family medical history; Gastric Mucosa - pathology; Gastroenterology and Hepatology; Humans; Image-enhanced endoscopy; Inflammation; Inflammatory bowel disease; Inflammatory Bowel Diseases - complications; Light; Mortality; Population Surveillance; Quality; Risk factors; SCENIC; Studies; Surveillance; SCENIC; Dysplasia; Colorectal cancer; Surveillance for Colorectal Endoscopic Neoplasia Detection and Management in IBD Patients International Consensus Recommendations; IBD; Chromoendoscopy; UC; Image-enhanced endoscopy; Inflammatory bowel disease; Surveillance; CRC; Colonoscopy; ulcerative colitis
• ISSN: 1521-6918; 1532-1916
• DOI: 10.1016/j.bpg.2016.10.014

Abstract Patients with inflammatory bowel disease involving the colon are at increased risk for developing colorectal cancer. Colonoscopy surveillance is important to identify and treat IBD associated dysplasia. The SCENIC consensus provides evidence-based recommendations for optimal surveillance and management of dysplasia in IBD. Chromoendoscopy, with the surface application of dyes to enhance mucosal visualization, is the superior endoscopic surveillance strategy to detect dysplasia. Most dysplasia is visible, and can be endoscopically resected. Future studies should determine the effect of new surveillance strategies on the incidence of CRC and mortality in patients with IBD.